- Home
- IMUX vs HURC Comparison
IMUX vs HURC Comparison
Compare IMUX & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- HURC
- Stock Information
- Founded
- IMUX 2016
- HURC 1968
- Country
- IMUX United States
- HURC United States
- Employees
- IMUX N/A
- HURC N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- HURC Industrial Machinery/Components
- Sector
- IMUX Health Care
- HURC Industrials
- Exchange
- IMUX Nasdaq
- HURC Nasdaq
- Market Cap
- IMUX 92.2M
- HURC 105.0M
- IPO Year
- IMUX N/A
- HURC N/A
- Fundamental
- Price
- IMUX $0.72
- HURC $16.53
- Analyst Decision
- IMUX Strong Buy
- HURC
- Analyst Count
- IMUX 5
- HURC 0
- Target Price
- IMUX $7.00
- HURC N/A
- AVG Volume (30 Days)
- IMUX 1.4M
- HURC 21.9K
- Earning Date
- IMUX 11-06-2025
- HURC 09-05-2025
- Dividend Yield
- IMUX N/A
- HURC N/A
- EPS Growth
- IMUX N/A
- HURC N/A
- EPS
- IMUX N/A
- HURC N/A
- Revenue
- IMUX N/A
- HURC $186,789,000.00
- Revenue This Year
- IMUX N/A
- HURC N/A
- Revenue Next Year
- IMUX N/A
- HURC N/A
- P/E Ratio
- IMUX N/A
- HURC N/A
- Revenue Growth
- IMUX N/A
- HURC N/A
- 52 Week Low
- IMUX $0.56
- HURC $13.19
- 52 Week High
- IMUX $1.42
- HURC $23.76
- Technical
- Relative Strength Index (RSI)
- IMUX 37.43
- HURC 34.46
- Support Level
- IMUX $0.67
- HURC $16.60
- Resistance Level
- IMUX $0.87
- HURC $18.39
- Average True Range (ATR)
- IMUX 0.05
- HURC 0.73
- MACD
- IMUX -0.01
- HURC -0.16
- Stochastic Oscillator
- IMUX 21.92
- HURC 4.80
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.